Published in Expert Opin Drug Deliv on August 20, 2014
M2 polarization enhances silica nanoparticle uptake by macrophages. Front Pharmacol (2015) 0.95
Nanomaterial-Enabled Cancer Therapy. Mol Ther (2017) 0.77
Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine. Int J Nanomedicine (2015) 0.76
Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents. Oxid Med Cell Longev (2016) 0.75
Size effect of Au/PAMAM contrast agent on CT imaging of reticuloendothelial system and tumor tissue. Nanoscale Res Lett (2016) 0.75
From iron coordination compounds to metal oxide nanoparticles. Beilstein J Nanotechnol (2016) 0.75
Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio. J Phys Chem B (2016) 0.75
Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment. Biosensors (Basel) (2017) 0.75
The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages. Nano Lett (2016) 0.75
The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev (2005) 7.56
Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol (2002) 1.79
Bioapplications of RAFT polymerization. Chem Rev (2009) 1.59
Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther Deliv (2011) 1.57
The generic enhancement of photochromic dye switching speeds in a rigid polymer matrix. Nat Mater (2005) 1.52
Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke (2002) 1.52
Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res (2004) 1.48
Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol (2003) 1.45
Novel CenterCross and MultiCross devices for the treatment of infrainguinal chronic total occlusions: initial single-centre experience. EuroIntervention (2016) 1.38
Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab (2010) 1.34
Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol (2005) 1.28
Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx (2005) 1.27
Well-defined protein-polymer conjugates via in situ RAFT polymerization. J Am Chem Soc (2007) 1.24
Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab (2009) 1.22
Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem (2009) 1.22
Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab (2010) 1.21
Smoking and ischemic stroke: a role for nicotine? Trends Pharmacol Sci (2002) 1.18
Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem (2007) 1.18
An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke (2012) 1.18
Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun (2005) 1.17
Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. Stroke (2008) 1.15
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Res (2004) 1.13
Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem (2007) 1.12
Temperature-responsive self-assembled monolayers of oligo(ethylene glycol): control of biomolecular recognition. ACS Nano (2008) 1.09
Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci (2002) 1.09
RAFT and click chemistry: a versatile approach to well-defined block copolymers. Chem Commun (Camb) (2006) 1.08
Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem (2008) 1.07
Reversible siRNA-polymer conjugates by RAFT polymerization. Chem Commun (Camb) (2008) 1.06
Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol (2005) 1.06
Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr Pharm Des (2013) 1.03
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des (2012) 1.03
CNS drug delivery: opioid peptides and the blood-brain barrier. AAPS J (2006) 1.02
Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. J Pharmacol Exp Ther (2010) 1.02
Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacol Rev (2013) 1.01
Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci (2003) 1.01
Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.00
An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. J Neurosci (2013) 1.00
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. Curr Pharm Des (2012) 0.98
Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res (2007) 0.97
P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. J Neurochem (2012) 0.97
Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem (2005) 0.96
In situ formation of protein-polymer conjugates through reversible addition fragmentation chain transfer polymerization. Angew Chem Int Ed Engl (2007) 0.96
One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles. Biomacromolecules (2008) 0.94
Synthesis of various glycopolymer architectures via RAFT polymerization: from block copolymers to stars. Biomacromolecules (2006) 0.94
Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res (2008) 0.93
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am J Physiol Heart Circ Physiol (2005) 0.91
Pain and the blood-brain barrier: obstacles to drug delivery. Adv Drug Deliv Rev (2003) 0.91
RAFT polymerization and thiol chemistry: a complementary pairing for implementing modern macromolecular design. Macromol Rapid Commun (2011) 0.90
Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res (2006) 0.90
Poly(vinyl alcohol) star polymers prepared via MADIX/RAFT polymerisation. Chem Commun (Camb) (2004) 0.90
Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Res (2004) 0.90
High-order multiblock copolymers via iterative Cu(0)-mediated radical polymerizations (SET-LRP): toward biological precision. J Am Chem Soc (2011) 0.90
Consistent experimental and theoretical evidence for long-lived intermediate radicals in living free radical polymerization. J Am Chem Soc (2004) 0.89
Efficient usage of thiocarbonates for both the production and the biofunctionalization of polymers. Macromol Rapid Commun (2009) 0.88
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des (2014) 0.88
Synthesis and bioactivity of poly(HPMA)-lysozyme conjugates: the use of novel thiazolidine-2-thione coupling chemistry. Org Biomol Chem (2009) 0.87
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clin Cancer Res (2005) 0.87
Synthesis of versatile thiol-reactive polymer scaffolds via RAFT polymerization. Biomacromolecules (2008) 0.86
Shell-cross-linked vesicles synthesized from block copolymers of Poly(D,L-lactide) and Poly(N-isopropyl acrylamide) as thermoresponsive nanocontainers. Langmuir (2004) 0.86
One-pot synthesis and biofunctionalization of glycopolymers via RAFT polymerization and thiol-ene reactions. Chem Commun (Camb) (2009) 0.86
Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am J Physiol Heart Circ Physiol (2003) 0.86
Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano (2013) 0.86
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol (2003) 0.85
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers. Mol Pharm (2013) 0.84
Amphiphilic block copolymers based on poly(2-acryloyloxyethyl phosphorylcholine) prepared via RAFT polymerisation as biocompatible nanocontainers. Macromol Biosci (2004) 0.83
Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture. J Pharmacol Exp Ther (2008) 0.83
Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention (2015) 0.83
Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism. Mol Pharmacol (2013) 0.83
Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. J Pharm Sci (2002) 0.83
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. Am J Physiol Heart Circ Physiol (2011) 0.83
Shell-cross-linked micelles containing cationic polymers synthesized via the RAFT process: toward a more biocompatible gene delivery system. Biomacromolecules (2007) 0.82
Functional iron oxide magnetic nanoparticles with hyperthermia-induced drug release ability by using a combination of orthogonal click reactions. Angew Chem Int Ed Engl (2013) 0.82
Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery. J Investig Med (2012) 0.82
Biodegradable star polymers functionalized with beta-cyclodextrin inclusion complexes. Biomacromolecules (2009) 0.81
Functional disulfide-stabilized polymer-protein particles. Biomacromolecules (2009) 0.81
Simultaneous polymerization-induced self-assembly (PISA) and guest molecule encapsulation. Macromol Rapid Commun (2013) 0.81
An approach to biodegradable star polymeric architectures using disulfide coupling. Chem Commun (Camb) (2008) 0.81
Branched polymer-protein conjugates made from mid-chain-functional P(HPMA). Biomacromolecules (2009) 0.81
Pluronic p85 block copolymer enhances opioid peptide analgesia. J Pharmacol Exp Ther (2002) 0.81
Synthesis, characterization, and multilayer assembly of pH sensitive graphene-polymer nanocomposites. Langmuir (2010) 0.81
Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. J Pharm Sci (2003) 0.81
Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. Eur J Pharmacol (2002) 0.81
Electrochemical impedance immunosensor based on gold nanoparticles and aryl diazonium salt functionalized gold electrodes for the detection of antibody. Biosens Bioelectron (2011) 0.80
Stabilization of polymer-hydrogel capsules via thiol-disulfide exchange. Small (2009) 0.80
Synthesis, multilayer film assembly, and capsule formation of macromolecularly engineered acrylic acid and styrene sulfonate block copolymers. Langmuir (2008) 0.80
Chemoenzymatic synthesis of narrow-polydispersity glycopolymers: poly(6-O-vinyladipoyl-D-glucopyranose). Biomacromolecules (2004) 0.80
Functional, star polymeric molecular carriers, built from biodegradable microgel/nanogel cores. Chem Commun (Camb) (2010) 0.80
Nano- and micro-engineering of ordered porous blue-light-emitting films by templating well-defined organic polymers around condensing water droplets. Angew Chem Int Ed Engl (2003) 0.79
Nanoparticle (star polymer) delivery of nitric oxide effectively negates Pseudomonas aeruginosa biofilm formation. Biomacromolecules (2014) 0.79
Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. Chem Commun (Camb) (2012) 0.78
First report of reversible addition-fragmentation chain transfer (RAFT) polymerisation in room temperature ionic liquids. Chem Commun (Camb) (2002) 0.78
In situ conjugation of dithiophenol maleimide polymers and oxytocin for stable and reversible polymer-peptide conjugates. Bioconjug Chem (2015) 0.78
Synthesis and high-throughput processing of polymeric hydrogels for 3D cell culture. Bioconjug Chem (2014) 0.78
Dicer-labile PEG conjugates for siRNA delivery. Biomacromolecules (2011) 0.78
In vitro cytotoxicity of RAFT polymers. Biomacromolecules (2010) 0.78
Thermoresponsive silver/polymer nanohybrids with switchable metal enhanced fluorescence. Chem Commun (Camb) (2012) 0.78
Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells. Phys Chem Chem Phys (2015) 0.78